Medico Remedies

{
  "main_header": {
    "sid": 1002925,
    "name": "Medico Remedies",
    "stock_name": "Medico Remedies",
    "full_name": "Medico Remedies Ltd",
    "name_url": "stocks-analysis/medico-remedies",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "47.18",
    "chg": -0.54,
    "chgp": "-1.13%",
    "dir": -1,
    "prev_price": "47.72",
    "mcapval": "392.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 540937,
    "symbol": "MEDICO",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE630Y01024",
    "curr_date": "Jan 19",
    "curr_time": "",
    "bse_nse_vol": "45.23 k",
    "exc_status": "Active",
    "traded_date": "Jan 19, 2026",
    "traded_date_str": "2026 01 19",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/medico-remedies-1002925-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Medico Remedies Ltd is Rated Hold",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/medico-remedies-ltd-is-rated-hold-3789661",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/MedicoRemediesL_mojoScore_3789661.png",
        "date": "2026-01-12 10:10:52",
        "description": "Medico Remedies Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 30 December 2025. However, the analysis and financial metrics discussed below reflect the stock's current position as of 12 January 2026, providing investors with an up-to-date perspective on the company’s performance and outlook."
      },
      {
        "title": "Why is Medico Remedies Ltd falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-medico-remedies-ltd-fallingrising-3787759",
        "imagepath": "",
        "date": "2026-01-10 01:36:27",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Recent Price Movement and Market Context</strong></p>\n<p>Medico Remedies Ltd closed at ₹48.00 on 09 January, down by ₹0.46 or 0.95% from the previous session. This decline continues a five-day losing streak, during which the stock has fallen by 5.25%. This underperformance is more pronounced than the broader Sensex index, which declined by 2.55% over the same one-week period. The stock’s year-to-date return also trails the benchmark, with a 5.06% drop compared to Sensex’s 1.93% fall.</p>\n<p>Over the longer term, the stock has struggled relative to the market. While the Sensex has delivered a 7.67% gain over the past year, Medico Remedies has declined by 21.18%. Even over three years, the stock is down 28.20%, contrasting sharply with the Sensex’s 37.58% rise. However, the five-year return re..."
      },
      {
        "title": "Medico Remedies Downgraded to Hold Amid Mixed Technicals and Valuation Concerns",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/medico-remedies-downgraded-to-hold-amid-mixed-technicals-and-valuation-concerns-3775834",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/MedicoRemediesL_mojoScore_3775834.png",
        "date": "2025-12-31 08:19:55",
        "description": "Medico Remedies Ltd, a key player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Buy to Hold as of 30 December 2025. This adjustment reflects a nuanced reassessment across quality, valuation, financial trends, and technical indicators, signalling a more cautious stance despite the company’s solid financial performance and operational strengths."
      },
      {
        "title": "Medico Remedies Ltd is Rated Buy",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/medico-remedies-ltd-is-rated-buy-3769183",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/MedicoRemediesL_mojoScore_3769183.png",
        "date": "2025-12-25 12:58:03",
        "description": "Medico Remedies Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 24 December 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 25 December 2025, providing investors with the most up-to-date view of the company’s fundamentals, returns, and technical outlook."
      },
      {
        "title": "Medico Remedies Hits Upper Circuit Amid Strong Buying Pressure and Robust Trading Activity",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/medico-remedies-surges-to-upper-circuit-on-robust-buying-momentum-3767242",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/MedicoRemedies_stocks_hitting_upper_circuit_3767242.png",
        "date": "2025-12-23 14:00:12",
        "description": "Medico Remedies Ltd witnessed a significant surge in its share price on 23 Dec 2025, hitting the upper circuit limit of 10%, reflecting intense buying interest and robust market participation. The stock outperformed its sector and broader indices, signalling heightened investor enthusiasm in this micro-cap pharmaceutical player."
      },
      {
        "title": "Medico Remedies: Analytical Perspective Shifts Amid Mixed Financial and Technical Signals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/medico-remedies-downgraded-to-hold-amid-mixed-technicals-and-valuation-concerns-3754881",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/MedicoRemedies_mojoScore_3754881.png",
        "date": "2025-12-10 08:25:18",
        "description": "Medico Remedies, a key player in the Pharmaceuticals & Biotechnology sector, has experienced a revision in its market assessment following a detailed evaluation of its quality, valuation, financial trends, and technical indicators. This article explores the factors influencing the recent changes in the company’s analytical perspective, providing investors with a comprehensive understanding of its current standing."
      },
      {
        "title": "Medico Remedies Sees Shift in Market Assessment Amid Strong Financial and Technical Signals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/medico-remedies-upgraded-to-buy-by-marketsmojo-on-strong-technical-and-financial-grounds-3747930",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/MedicoRemedies_mojoScore_3747930.png",
        "date": "2025-12-05 08:14:51",
        "description": "Medico Remedies, a key player in the Pharmaceuticals & Biotechnology sector, has experienced a notable revision in its market evaluation, reflecting a combination of robust financial results and evolving technical indicators. This shift highlights the company's recent performance across quality, valuation, financial trends, and technical parameters, offering investors a comprehensive view of its current standing."
      },
      {
        "title": "How has been the historical performance of Medico Remedies?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/how-has-been-the-historical-performance-of-medico-remedies-3747127",
        "imagepath": "",
        "date": "2025-12-04 22:51:46",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Revenue Growth and Operating Performance</strong></p>\n<p>Over the past seven years, Medico Remedies has seen its net sales rise from ₹97.69 crores in March 2019 to ₹150.94 crores in March 2025, reflecting a robust compound growth trend. The company’s total operating income mirrors this progression, with no other operating income reported, indicating a primary reliance on core business activities. Raw material costs have naturally increased in line with sales, reaching ₹111.39 crores in the latest fiscal year, while employee costs have also risen steadily, signalling investment in human capital to support expansion.</p>\n<p>Operating profit before depreciation and interest (PBDIT) excluding other income has improved significantly, from ₹2.76 crores in 2019 to ₹15.00 crores in 2025. When factor..."
      },
      {
        "title": "Medico Remedies Sees Revision in Market Evaluation Amidst Mixed Financial Signals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/medico-remedies-upgraded-from-sell-to-hold-by-marketsmojo-on-12-nov-2025-3746591",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/MedicoRemedies_mojoScore_3746591.png",
        "date": "2025-12-04 11:08:06",
        "description": "Medico Remedies, a microcap player in the Pharmaceuticals & Biotechnology sector, has experienced a revision in its market evaluation reflecting a nuanced shift in its financial and technical outlook. This adjustment follows a detailed reassessment of the company’s quality, valuation, financial trends, and technical indicators, offering investors a refreshed perspective on its market position."
      }
    ],
    "total": 155,
    "sid": "1002925",
    "stock_news_url": "https://www.marketsmojo.com/news/medico-remedies-1002925"
  },
  "announcements": [
    {
      "caption": "Closure of Trading Window",
      "datetime": "30-Dec-2025",
      "details": "Please find enclosed disclosure with regards to closure of trading window",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Outcome for Outcome",
      "datetime": "14-Nov-2025",
      "details": "Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we hereby inform you that the Board of Directors of our Company at their meeting held today i.e. 14th November 2025 has inter alia considered and approved the following: 1. Unaudited Standalone Financial Results for the quarter and half year ended 30th September 2025 alongwith Auditors Limited Review Report thereon; (enclosed) We wish to inform you that the Board Meeting commenced today at 5:00 P.M. and concluded at 06:55 P.M. Kindly take the same on record",
      "source": "BSE"
    },
    {
      "caption": "Disclosure Under Regulation 30 Of Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015- Issuance Of GMP Compliance Certificate By The State Service Of Ukraine On Medicines And Drugs Control",
      "datetime": "14-Nov-2025",
      "details": "Please find attached Disclosure under Regulation 30 of SEBI (LODR) Regulations 2015",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Medico Remedies Ltd has announced <strong>2:10</strong> stock split, ex-date: 16 Mar 23",
          "dt": "2023-03-16",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Medico Remedies Ltd has announced <strong>3:1</strong> bonus issue, ex-date: 16 Nov 21",
          "dt": "2021-11-16",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Medico Remedies Ltd is Rated Hold

2026-01-12 10:10:52

Medico Remedies Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 30 December 2025. However, the analysis and financial metrics discussed below reflect the stock's current position as of 12 January 2026, providing investors with an up-to-date perspective on the company’s performance and outlook.

Read full news article

Why is Medico Remedies Ltd falling/rising?

2026-01-10 01:36:27

Recent Price Movement and Market Context

Medico Remedies Ltd closed at ₹48.00 on 09 January, down by ₹0.46 or 0.95% from the previous session. This decline continues a five-day losing streak, during which the stock has fallen by 5.25%. This underperformance is more pronounced than the broader Sensex index, which declined by 2.55% over the same one-week period. The stock’s year-to-date return also trails the benchmark, with a 5.06% drop compared to Sensex’s 1.93% fall.

Over the longer term, the stock has struggled relative to the market. While the Sensex has delivered a 7.67% gain over the past year, Medico Remedies has declined by 21.18%. Even over three years, the stock is down 28.20%, contrasting sharply with the Sensex’s 37.58% rise. However, the five-year return re...

Read full news article

Medico Remedies Downgraded to Hold Amid Mixed Technicals and Valuation Concerns

2025-12-31 08:19:55

Medico Remedies Ltd, a key player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Buy to Hold as of 30 December 2025. This adjustment reflects a nuanced reassessment across quality, valuation, financial trends, and technical indicators, signalling a more cautious stance despite the company’s solid financial performance and operational strengths.

Read full news article

Medico Remedies Ltd is Rated Buy

2025-12-25 12:58:03

Medico Remedies Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 24 December 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 25 December 2025, providing investors with the most up-to-date view of the company’s fundamentals, returns, and technical outlook.

Read full news article

Medico Remedies Hits Upper Circuit Amid Strong Buying Pressure and Robust Trading Activity

2025-12-23 14:00:12

Medico Remedies Ltd witnessed a significant surge in its share price on 23 Dec 2025, hitting the upper circuit limit of 10%, reflecting intense buying interest and robust market participation. The stock outperformed its sector and broader indices, signalling heightened investor enthusiasm in this micro-cap pharmaceutical player.

Read full news article

Medico Remedies: Analytical Perspective Shifts Amid Mixed Financial and Technical Signals

2025-12-10 08:25:18

Medico Remedies, a key player in the Pharmaceuticals & Biotechnology sector, has experienced a revision in its market assessment following a detailed evaluation of its quality, valuation, financial trends, and technical indicators. This article explores the factors influencing the recent changes in the company’s analytical perspective, providing investors with a comprehensive understanding of its current standing.

Read full news article

Medico Remedies Sees Shift in Market Assessment Amid Strong Financial and Technical Signals

2025-12-05 08:14:51

Medico Remedies, a key player in the Pharmaceuticals & Biotechnology sector, has experienced a notable revision in its market evaluation, reflecting a combination of robust financial results and evolving technical indicators. This shift highlights the company's recent performance across quality, valuation, financial trends, and technical parameters, offering investors a comprehensive view of its current standing.

Read full news article

How has been the historical performance of Medico Remedies?

2025-12-04 22:51:46

Revenue Growth and Operating Performance

Over the past seven years, Medico Remedies has seen its net sales rise from ₹97.69 crores in March 2019 to ₹150.94 crores in March 2025, reflecting a robust compound growth trend. The company’s total operating income mirrors this progression, with no other operating income reported, indicating a primary reliance on core business activities. Raw material costs have naturally increased in line with sales, reaching ₹111.39 crores in the latest fiscal year, while employee costs have also risen steadily, signalling investment in human capital to support expansion.

Operating profit before depreciation and interest (PBDIT) excluding other income has improved significantly, from ₹2.76 crores in 2019 to ₹15.00 crores in 2025. When factor...

Read full news article

Medico Remedies Sees Revision in Market Evaluation Amidst Mixed Financial Signals

2025-12-04 11:08:06

Medico Remedies, a microcap player in the Pharmaceuticals & Biotechnology sector, has experienced a revision in its market evaluation reflecting a nuanced shift in its financial and technical outlook. This adjustment follows a detailed reassessment of the company’s quality, valuation, financial trends, and technical indicators, offering investors a refreshed perspective on its market position.

Read full news article

View All News